Concepedia

J. Capdevila Castillón

JC

Statistics

Publications

3

Citations

35

H-Index

3

Active since

2022

Affiliations

Hospital Universitario La Paz(Current)

MD Anderson Cancer Center Madrid

Hospital Universitario Ramón y Cajal

Instituto de Investigación Biomédica de Málaga

Vall d'Hebron Hospital Universitari

J. Capdevila Castillón is an author at Hospital Universitario La Paz specializing in cancer research, molecular oncology, and cancer therapeutics.

Top concepts

Publications per year

2022–2023

3

Publications

3

496MO Final overall survival results from the NICE-NEC trial (GETNE-T1913): A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin

María Carmen Riesco Martínez, J. Capdevila Castillón, V. Alonso et al. · Annals of Oncology · 2022 · 12 citations

, , +9

723O Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multi-cohort basket phase II trial (CABATEN/GETNE-T1914)

J. Capdevila Castillón, Javier Molina‐Cerrillo, Marta Benavent Viñuales et al. · Annals of Oncology · 2023 · 12 citations · Full text

1645O Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial

J. Capdevila Castillón, M. Plana, B. Castelo et al. · Annals of Oncology · 2022 · 11 citations

1–3 of 3